Atossa Genetics (www.atossagenetics.com) has an FDA-approved test for pre-cancerous changes for breast cancer that includes patents to Ki67, one of the biomarkers in this study.
U.S. News's "Best" delivers recognized, authoritative information and clear, objective rankings that help readers plan for their life and ultimately, make the most of it.
Reader Comments
Back to article
Steven Quay MD, PhD of WA 8:58PM April 29, 2010